Low Pressure Pneumoperitoneum and Deep Neuromuscular Block Versus Standard Laparoscopy During Robot Assisted Radical Prostatectomy to Improve the Quality of Recovery and Immune Homeostasis; Study Protocol for a Randomized Controlled Study. (RECOVER-2)
Primary Purpose
Quality of Life, Postoperative Complications, Acute Pain
Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Low intra-abdominal pressure
Deep neuromuscular blockade (NMB)
Standard intra-abdominal pressure
Moderate neuromuscular blockade (NMB)
Sponsored by
About this trial
This is an interventional prevention trial for Quality of Life
Eligibility Criteria
Inclusion Criteria:
- - Age ≥ 18 years
- Undergoing elective robot assisted radical prostatectomy (RARP)
- Obtained informed consent
Exclusion Criteria:
- Laparoscopic radical prostatectomy without robot assistance
- Insufficient control of the Dutch language to read the patient information and to fill out de questionnaires
- Neo-adjuvant chemotherapy
- Chronic use of analgesics or psychotropic drugs
- Use of NSAID's shorter than 5 days before surgery
- Severe liver- or renal disease
- Neuromuscular disease
- Hyperthyroidism or thyroid adenomas
- Deficiency of vitamin K dependent clotting factors or coagulopathy
- Planned diagnostics or treatment with radioactive iodine < 1 week after surgery
- Indication for rapid sequence induction
- BMI >35kg/m2
- Known of suspected hypersensitivity to ICG, sodium iodide, iodine, rocuronium or sugammadex
- Use of medication interfering with ICG absorption as listed in the summary of product characteristics (SPC); anticonvulsants, bisulphite compounds, haloperidol, heroin, meperidine, metamizol, methadone, morphium, nitrofurantoin, opium alkaloids, phenobarbital, phenylbutazone, cyclopropane, probencid
Sites / Locations
- Canisius Wilhelmina ziekenhuis
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Experimental group: Low Impact laparoscopy
Control group: Standard laparoscopy
Arm Description
low impact laparoscopy (low pressure (8 mmHg) and deep NMB (PTC 1-2)
standard laparoscopy (standard pressure (14 mmHg) and moderate NMB (TOF 1-2)
Outcomes
Primary Outcome Measures
Quality of recovery - 40 items questionnaire score (QoR-40)
40 points (minimum: extremely poor quality of recovery) to 200 points (maximum: excellent quality of recovery)
Immune response represented by IL-6
IL-6 response upon whole blood LPS stimulation
Immune response represented by IL-10
IL-10 response upon whole blood LPS stimulation
Perfusion index of the parietal peritoneum
calculated from the slope of ICG fluorescence intensity, and time to maximal intensity in seconds. (extracted from video registration).
Secondary Outcome Measures
Quality of recovery - 40 items questionnaire score (QoR-40)
40 points (minimum: extremely poor quality of recovery) to 200 points (maximum: excellent quality of recovery)
Health status with short form survey (SF-36)
The lower the score the more disability. The higher the score the less disability.
Chronic pain with McGill pain questionnaire (MPQ)
range from 0 (no pain) to 78 (severe pain)
Pain score with VAS
pain scores with VAS 0 (no pain) to 10 (severe pain)
Analgesia use
non-cumulative and cumulative opioid use per day in morphine equivalent
PONV
With PONV impact scale score o (no PONV) to 6 (extreme PONV)
Hospital stay
length of hospital stay in days
Postoperative recovery time
time to reach discharge criteria in days
Operating conditions
surgical conditions with L-SRS 0 (extremely poor work field) to 5 (excellent work field)
Complications
postoperative complications scored by Clavien Dindo classification; grade 0 (no deviation from ideal) grade 5 (death of patient)
Full Information
NCT ID
NCT04250883
First Posted
January 29, 2020
Last Updated
May 9, 2022
Sponsor
Radboud University Medical Center
Collaborators
Merck Sharp & Dohme LLC
1. Study Identification
Unique Protocol Identification Number
NCT04250883
Brief Title
Low Pressure Pneumoperitoneum and Deep Neuromuscular Block Versus Standard Laparoscopy During Robot Assisted Radical Prostatectomy to Improve the Quality of Recovery and Immune Homeostasis; Study Protocol for a Randomized Controlled Study.
Acronym
RECOVER-2
Official Title
Low Pressure Pneumoperitoneum and Deep Neuromuscular Blockade Versus Standard Laparoscopy During RARP to Improve the Quality of Recovery and Immune Homeostasis; Study Protocol for a Randomized Controlled Study
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
December 24, 2020 (Actual)
Primary Completion Date
December 9, 2021 (Actual)
Study Completion Date
March 7, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Radboud University Medical Center
Collaborators
Merck Sharp & Dohme LLC
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Intra-abdominal pressure (IAP) needed to create sufficient workspace during laparoscopic surgery affects the surrounding organs with ischemia-reperfusion injury and a systemic immune response. This effect is related to postoperative recovery, pain scores, opioid consumption, bowel function recovery, morbidity and possibly mortality. In clinical practice standard pressures of 12-16mmHg are applied instead of the lowest possible IAP, but accumulating evidence shows lower pressure pneumoperitoneum (PNP) (6-8mmHg) to be non-compromising for sufficient workspace, when combined with deep neuromuscular blockade (NMB) in a vast majority of patients. Therefore, low impact laparoscopy, meaning low pressure PNP facilitated by deep NMB, could be a valuable addition to Enhanced Recovery After Surgery (ERAS) Protocols.
The use of low pressure PNP may also reduce hypoxic injury and the release of DAMPs and thereby contributing to a better preservation of innate immune function which may help to reduce the risk of infectious complications.
The participants will be randomly assigned to one of the experimental groups with low impact laparoscopy or one of the control groups with standard laparoscopy.
Detailed Description
Intra-abdominal pressure (IAP) needed to create sufficient workspace during laparoscopic surgery affects the surrounding organs with ischemia-reperfusion injury and a systemic immune response. This effect is related to postoperative recovery, pain scores, opioid consumption, bowel function recovery, morbidity and possibly mortality. Therefore, low impact laparoscopy, meaning low pressure PNP facilitated by deep NMB, could be a valuable addition to Enhanced Recovery After Surgery (ERAS) Protocols.
The use of low pressure PNP may also reduce hypoxic injury and the release of DAMPs and thereby contributing to a better preservation of innate immune function which may help to reduce the risk of infectious complications.
The participants will be randomly assigned to the experimental group 1: low impact laparoscopy (low pressure (8 mmHg) and deep NMB (PTC 1-2)); 8 mmHg IAP after trocar introduction for perfusion measurement or the experimental group 2: low impact laparoscopy (low pressure (8 mmHg) and deep NMB (PTC 1-2)); 12 mmHg IAP after trocar introduction for perfusion measurement, or control group 1: standard laparoscopy (standard pressure (12 mmHg) and moderate NMB (TOF 1-2)); 8 mmHg IAP after trocar introduction for perfusion measurement, or control group 2: standard laparoscopy (standard pressure (12 mmHg) and moderate NMB (TOF 1-2)); 12 mmHg IAP after trocar introduction for perfusion measurement.
ICG injection will take place with starting pressure to quantify parietal peritoneum perfusion, and a parietal peritoneal biopsy will be taken. At the end of surgery, a second parietal peritoneum biopsy will be taken.
NB: After introduction of the camera trocar, insufflation of carbon dioxide is titrated to an IAP of 8mmHg in group A and C, and 14 mmHg in group B and D. After placement of the last trocar the injection of ICG and video registration of peritoneum will take place, and a peritoneal biopsy will be taken. There after surgery will take place with an IAP of 14mmHg in the control groups (C and D), and an IAP of 8mmHg in the experimental groups (A and B). In the control groups (C and D)
Pre- and postoperative a few questionnaires will be taken and blood withdrawals to evaluate the quality of recovery, and the immune response.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Quality of Life, Postoperative Complications, Acute Pain, Immune System Tolerance
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Randomized
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
96 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Experimental group: Low Impact laparoscopy
Arm Type
Experimental
Arm Description
low impact laparoscopy (low pressure (8 mmHg) and deep NMB (PTC 1-2)
Arm Title
Control group: Standard laparoscopy
Arm Type
Active Comparator
Arm Description
standard laparoscopy (standard pressure (14 mmHg) and moderate NMB (TOF 1-2)
Intervention Type
Other
Intervention Name(s)
Low intra-abdominal pressure
Intervention Description
8 mmHg
Intervention Type
Other
Intervention Name(s)
Deep neuromuscular blockade (NMB)
Intervention Description
Deep NMB (PTC1-2)
Intervention Type
Other
Intervention Name(s)
Standard intra-abdominal pressure
Intervention Description
14 mmHg
Intervention Type
Other
Intervention Name(s)
Moderate neuromuscular blockade (NMB)
Intervention Description
Moderate NMB (TOF 1-2)
Primary Outcome Measure Information:
Title
Quality of recovery - 40 items questionnaire score (QoR-40)
Description
40 points (minimum: extremely poor quality of recovery) to 200 points (maximum: excellent quality of recovery)
Time Frame
at postoperative day 1
Title
Immune response represented by IL-6
Description
IL-6 response upon whole blood LPS stimulation
Time Frame
at postoperative day 1
Title
Immune response represented by IL-10
Description
IL-10 response upon whole blood LPS stimulation
Time Frame
at postoperative day 1
Title
Perfusion index of the parietal peritoneum
Description
calculated from the slope of ICG fluorescence intensity, and time to maximal intensity in seconds. (extracted from video registration).
Time Frame
From ICG injection, up to 20 seconds
Secondary Outcome Measure Information:
Title
Quality of recovery - 40 items questionnaire score (QoR-40)
Description
40 points (minimum: extremely poor quality of recovery) to 200 points (maximum: excellent quality of recovery)
Time Frame
day 10 after surgery
Title
Health status with short form survey (SF-36)
Description
The lower the score the more disability. The higher the score the less disability.
Time Frame
day 10 and 3 months after surgery
Title
Chronic pain with McGill pain questionnaire (MPQ)
Description
range from 0 (no pain) to 78 (severe pain)
Time Frame
3 months after surgery
Title
Pain score with VAS
Description
pain scores with VAS 0 (no pain) to 10 (severe pain)
Time Frame
During hospital stay up to 3 days
Title
Analgesia use
Description
non-cumulative and cumulative opioid use per day in morphine equivalent
Time Frame
During hospital stay up to 3 days
Title
PONV
Description
With PONV impact scale score o (no PONV) to 6 (extreme PONV)
Time Frame
During hospital stay up to 3 days
Title
Hospital stay
Description
length of hospital stay in days
Time Frame
from admission up to 3 days
Title
Postoperative recovery time
Description
time to reach discharge criteria in days
Time Frame
From day of surgery up to 3 days
Title
Operating conditions
Description
surgical conditions with L-SRS 0 (extremely poor work field) to 5 (excellent work field)
Time Frame
During operation for up to 8 hours
Title
Complications
Description
postoperative complications scored by Clavien Dindo classification; grade 0 (no deviation from ideal) grade 5 (death of patient)
Time Frame
Day of surgery untill 30days after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 18 years
Undergoing elective robot assisted radical prostatectomy (RARP)
Obtained informed consent
Exclusion Criteria:
Laparoscopic radical prostatectomy without robot assistance
Insufficient control of the Dutch language to read the patient information and to fill out de questionnaires
Neo-adjuvant chemotherapy
Chronic use of analgesics or psychotropic drugs
Use of NSAID's shorter than 5 days before surgery
Severe liver- or renal disease
Neuromuscular disease
Hyperthyroidism or thyroid adenomas
Deficiency of vitamin K dependent clotting factors or coagulopathy
Planned diagnostics or treatment with radioactive iodine < 1 week after surgery
Indication for rapid sequence induction
BMI >35kg/m2
Known of suspected hypersensitivity to ICG, sodium iodide, iodine, rocuronium or sugammadex
Use of medication interfering with ICG absorption as listed in the summary of product characteristics (SPC); anticonvulsants, bisulphite compounds, haloperidol, heroin, meperidine, metamizol, methadone, morphium, nitrofurantoin, opium alkaloids, phenobarbital, phenylbutazone, cyclopropane, probencid
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michiel Warle, Dr.
Organizational Affiliation
Radboud University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Canisius Wilhelmina ziekenhuis
City
Nijmegen
Country
Netherlands
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
All data will be analyzed for publication. After that it belongs to Radboud umc where other researchers of Radboud umc may or may not include this database to their study. But there will be no active sharing
Learn more about this trial
Low Pressure Pneumoperitoneum and Deep Neuromuscular Block Versus Standard Laparoscopy During Robot Assisted Radical Prostatectomy to Improve the Quality of Recovery and Immune Homeostasis; Study Protocol for a Randomized Controlled Study.
We'll reach out to this number within 24 hrs